Aegerion Pharmaceuticals Inc. (AEGR) reported a first quarter non-GAAP loss of $0.25 per share after the bell Tuesday, compared to the loss of $0.51 a year ago.
Aegerion Pharmaceuticals gapped open sharply lower Wednesday and is now down 9.82 at $34.34 on above average volume. The stock has plummeted to a new low for the year.
For comments and feedback contact: editorial@rttnews.com
Business News